Josep Franch-Nadal1, Javier Mediavilla-Bravo2, Manuel Mata-Cases3, Didac Mauricio4, David Asensio5, Jordi Sarroca5. 1. Fundación redGDPS, España; Equip d'Atenció Primària Raval Sud, Institut Català de la Salut, Barcelona, España; DAP_cat, Unitat de Suport a la Recerca Barcelona ciutat, IDIAP Jordi Gol, Barcelona, España; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, España. Electronic address: josep.franch@gmail.com. 2. Fundación redGDPS, España; Centro de Salud Burgos Rural, Sanidad de Castilla y León (SACYL), Burgos, España. 3. Fundación redGDPS, España; DAP_cat, Unitat de Suport a la Recerca Barcelona ciutat, IDIAP Jordi Gol, Barcelona, España. 4. Fundación redGDPS, España; DAP_cat, Unitat de Suport a la Recerca Barcelona ciutat, IDIAP Jordi Gol, Barcelona, España; Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España. 5. Departamento Médico de Almirall, Barcelona, España.
Abstract
OBJECTIVE: To describe the prevalence of known and ignored type 2 diabetes mellitus (T2DM) among primary care physicians (PCP), as well as the treatment used and the degree of metabolic control reached. MATERIAL AND METHODS: Descriptive cross-sectional study on national level. The participants were randomly selected PCPs, members of the redGDPS Foundation. A total of 495 PCP were enrolled. Capillary HbA1c measurement was done with a A1CNow+® device and a diabetes-related survey specifically designed for the study was administered to the participants. RESULTS: The total prevalence of T2DM was 11.1% (95% CI 8.33-13.9) (known disease 8,1% and ignored disease 3.0%). The prevalence of prediabetes was 16.2% (95% CI 13.0-19.4). A total of 62.5% of PCPs with known T2DM reached HbA1c<7% and 15% had HbA1c>8.5%. Control of blood pressure (BP<140/90mmHg) was reached in 87.5% and control of LDL cholesterol<130mg/dl with no history of cardiovascular disease was reached in 88.6% of cases of known T2DM. In the PCPs with a history of macrovascular disease, good control of LDL was reached in 42.9% of the cases. A total of 12.5% were active smokers. A total of 71.4% of PCPs with known T2DM self-treated their own disease, usually with 2 or more drugs (51.4%). The most commonly used drug was metformin (74.3%) followed by iDPP4 (48.6%). CONCLUSIONS: PCPs with T2DM have better metabolic control than the general population. It is necessary to study whether PCPs with T2DM may have greater adherence to treatment and do they achieve a better metabolic control.
OBJECTIVE: To describe the prevalence of known and ignored type 2 diabetes mellitus (T2DM) among primary care physicians (PCP), as well as the treatment used and the degree of metabolic control reached. MATERIAL AND METHODS: Descriptive cross-sectional study on national level. The participants were randomly selected PCPs, members of the redGDPS Foundation. A total of 495 PCP were enrolled. Capillary HbA1c measurement was done with a A1CNow+® device and a diabetes-related survey specifically designed for the study was administered to the participants. RESULTS: The total prevalence of T2DM was 11.1% (95% CI 8.33-13.9) (known disease 8,1% and ignored disease 3.0%). The prevalence of prediabetes was 16.2% (95% CI 13.0-19.4). A total of 62.5% of PCPs with known T2DM reached HbA1c<7% and 15% had HbA1c>8.5%. Control of blood pressure (BP<140/90mmHg) was reached in 87.5% and control of LDL cholesterol<130mg/dl with no history of cardiovascular disease was reached in 88.6% of cases of known T2DM. In the PCPs with a history of macrovascular disease, good control of LDL was reached in 42.9% of the cases. A total of 12.5% were active smokers. A total of 71.4% of PCPs with known T2DM self-treated their own disease, usually with 2 or more drugs (51.4%). The most commonly used drug was metformin (74.3%) followed by iDPP4 (48.6%). CONCLUSIONS: PCPs with T2DM have better metabolic control than the general population. It is necessary to study whether PCPs with T2DM may have greater adherence to treatment and do they achieve a better metabolic control.
Authors: Carmen Valdés Y Llorca; Ernesto Cortés Castell; José Manuel Ribera Casado; Pilar de Lucas Ramos; José Luis Casteig Ayestarán; Amaia Casteig Blanco; Vicente Francisco Gil Guillén; Mercedes Rizo Baeza Journal: Int J Environ Res Public Health Date: 2021-04-19 Impact factor: 3.390
Authors: Jessica Ruiz-Toledo; Antonio J Zalacain-Vicuña; Elena de Planell-Mas Journal: Int J Environ Res Public Health Date: 2021-05-11 Impact factor: 3.390